Cell therapy and oncology–focused Carisma Therapeutics started layoffs late last year. Now the company plans to wind down ...
Pharmaceutical Technology on MSN8d
FDA approves IND application for Everest’s cancer vaccineEVM14 is the first messenger RNA (mRNA) therapeutic vaccine developed internally by the company to gain this approval. Its ...
9h
MEPSGEN US Inc., a global innovator in scalable nanoparticle production technology, announced today the launch of NanoCalibur™, a cutting-edge, scalable nanoparticle (NP) production system in the ...
Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...
Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced its financial results for the fourth quarter and fiscal year 2024, ...
As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and ...
Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.
ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA ...
US FDA clears Everest Medicines’ IND application for tumour-associated antigen vaccine, EVM14: Shanghai, China Tuesday, March 25, 2025, 15:00 Hrs [IST] Everest Medicines, a biop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback